BAYZF (Bayer AG) FFO


BAYZF Bayer AG BAYZF
53 GF Score
Price $53.20
GF Value $31.90
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Bayer AG FFO?

FFO (Funds from operations) only applies to REITs.

BAYZF
53GF Score
Bayer AG BAYZF
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bayer AG (BAYZF) Overvalued in 2026?

Based on GuruFocus' analysis, Bayer AG stock appears to be overvalued. The current stock price of $53.20 is trading 66.8% above its estimated GF Value™ of $31.90. GuruFocus considers Bayer AG to be Significantly Overvalued.

Key valuation signals for BAYZF:

  • FFO:
  • GF Value™: $31.90 vs. price of $53.20 (66.8% above fair value)
  • GF Score™: 53/100 with 2 warning signs

No single metric tells the full story. See the BAYZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bayer AG Business Description

Address Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs (about 38% of total sales in 2025) as well as vitamins and other consumer healthcare products (13% of total). The firm's crop science business (47% of total) sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
53GF Score

Get the complete analysis for BAYZF

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$53.20
Price
$31.90
GF Value